Course: Improving Real-World Care For Veteran Patients With Hepatocellular Carcinoma
Released: 0000-00-00
Program Description
Click to Go to the Event Registration
Join us for an engaging discussion that will delve into real-world data and insights gleaned from Veterans Affairs (VA) care teams across the US who participated in a quality improvement initiative aimed at enhancing personalized treatment and guideline-recommended care for patients with hepatocellular carcinoma (HCC).
Expert faculty will reflect on findings from patient and provider surveys, provider workshops, and action plans developed by clinical teams to advance risk-based, personalized care for patients with HCC.
Gain a firsthand look at the strategies implemented by clinicians who care for veterans with HCC and engage with expert faculty in live Q&A.
This webinar is delivered in partnership with Blue Faery: The Adrienne Wilson Liver Cancer Association.
Agenda
I. Key Findings on Real-World HCC Care Experiences and Challenges in VA Settings
II. Unique Care Considerations for Veterans With HCC
III. Applying Staging and Risk Assessment to Identify Patients With HCC at High Risk for Recurrence
IV. Case-Based Discussion: Applying the Latest Clinical Evidence to Individualize Risk-Based Treatment Selection, Timing, and Sequencing
V. Effective Multidisciplinary Strategies to Optimize Quality Care for Patients With HCC
Intended Audience
VA affiliated clinical teams caring for patients with HCC (including oncologists, hepatic surgeons, hepatologists, interventional radiologists, NPs/PAs, nurses, and pharmacists)
Commercial Supporter
This activity is supported by an educational grant from Genentech, a member of the Roche Group.
Learning Objectives
Upon completion of this activity, learners should be able to:
Assess considerations of care in veterans with hepatocellular carcinoma (HCC) to overcome barriers to appropriate treatment and ongoing management
Evaluate current guidelines and recent clinical trial data on best practices for the use of systemic therapy for the treatment of HCC
Apply current evidence to identify of appropriate patients for systemic treatment and individualized management decisions for patients with HCC in VA settings
Differentiate systemic therapies based on recommendations and the latest clinical data on HCC treatment and patient-centered outcomes
Employ interprofessional strategies to support evidence-based integration of best practices into HCC management based on current VA policies, application of guideline recommendations for treatment, and patient counseling on the benefit-risk profile of various treatment options
View Full Course